Public annual accounts

APTEC DIAGNOSTICS financials

Name: APTEC DIAGNOSTICS financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for APTEC DIAGNOSTICS, with comparable measures and links to available source documents.

Company overview

Registry number

0451876874

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for APTEC DIAGNOSTICS

2025 versus 2024

Operating line: €1,329,693
EBITDA: €432,223
Total assets: €4,597,675
Equity: €3,360,261

EBITDA margin +32.5% · Equity ratio +73.1%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€1,329,693	€432,223	€4,597,675	€3,360,261	-
202431 Dec 2024	€2,485,173	€1,336,371	€4,471,149	€3,088,463	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202531 Dec 2025

€1,329,693

€432,223

€4,597,675

€3,360,261

202431 Dec 2024

€2,485,173

€1,336,371

€4,471,149

€3,088,463